Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022) by Reilly, TJ

Menopausal hormone therapy for women with schizophrenia: what’s stopping us? by Reilly, TJ, McCutcheon, RA

A case series of premenstrual disorders presenting to the UK's National Female Hormone Clinic by Reilly, TJ, Knox, C-L, Marsh, MS, Craig, MC

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study by Hurşitoğlu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ

Get full text

Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: a systematic review and meta-analysis of randomised trials by Reilly, TJ, Wallman, P, Clark, I, Knox, C-L, Craig, MC, Taylor, D

Systematic review of the association between adverse life events and the onset and relapse of postpartum psychosis by Reilly, TJ, Roberts, E, Sagnay De La Bastida, VC, McGuire, P, Dazzan, P, Cullen, AE

The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis by Reilly, TJ, Patel, S, Unachukwu, I, Knox, C-L, Wilson, CA, Craig, MC, Schmalenberger, KM, Eisenlohr-Moul, TA, Cullen, AE

Point of care assay for blood aripiprazole concentrations: development, validation and utility by Atkins, M, Taylor, D, Catalan, A, Desouza, N, Chesney, E, Reilly, TJ, Baburina, I, Hilaire, MR, Dratcu, L, Harland, R, Salamone, SJ, McGuire, P